Skip to main content

Table 1 Clinical-pathological data of sarcomas’ patients

From: Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub-cellular localization

Variable n %
Age   
 >51 48 56.5
 ≤51 37 43.5
Gender   
 Female 33 38.8
 Male 52 61.2
Race   
 Caucasian 63 74.1
 Not Caucasian 22 25.9
Local   
 Lower extremities 63 73.3
 Upper extremities 23 26.7
Diagnostic   
 Pleomorphic leiomyosarcoma 17 19.8
 Myxoid/round cells liposarcoma 14 16.3
 High grade undifferentiated pleomorphic sarcoma 12 14.0
 Monophasic fibrous synovial sarcoma 9 10.5
 Myxofibrosarcoma 7 8.1
 Malignant peripheral nerve sheath tumor 7 8.1
 Low grade fibromyxoid sarcoma 3 3.5
 Poorly differentiated synovial sarcoma 2 2.3
 High grade myofibroblastic sarcoma 2 2.3
 Clear cell sarcoma 1 1.2
 Biphasic synovial sarcoma 1 1.2
 Fibrosarcoma 1 1.2
 Angiomatoid histiocytoma 1 1.2
 Infantile fibrosarcoma 1 1.2
 Well differentiated liposarcoma 1 1.2
 Undifferentiated liposarcoma 1 1.2
 Pleomorphic liposarcoma 1 1.2
 Acral myxoinflammatory fibroblastic sarcoma 1 1.2
 Low grade myofibroblastic sarcoma 1 1.2
 Giant-cell-rich high grade undifferentiated pleomorphic sarcoma 1 1.2
 Malignant solitary fibrous tumor 1 1.2
 Alveolar sarcoma 1 1.2
Cell lineage   
 Fibroblastic/myofibroblastic 28 32.5
 Smooth muscle 17 19.8
 Lipogenic 17 19.8
 Peripheral nerve 7 8.1
 Miscellaneous 17 19.8
Cellular pleomorphism   
 Absence of pleomorphic cells 54 62.8
 Presence of pleomorphic cells 32 37.2
Grade   
 Low grade (I) 30 32.2
 High grade (II e III) 63 67.7
Disease progression   
 No 25 30.9
 Yes 56 69.1
Disease recurrence   
 Absent 48 57.1
 Present 36 42.9
Metastasis   
 Absent 44 52.4
 Present 40 47.6
  1. Significant values are shown in bold.